Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Service & Software > Custom Adeno-Associated Virus (AAV) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Custom Adeno-Associated Virus (AAV) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Custom Adeno-Associated Virus (AAV) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published: 2025-03-11

Pages: 169 Pages

Report ld: 4641384

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Custom Adeno-Associated Virus (AAV) Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Custom Adeno-Associated Virus (AAV) services refer to specialized biotechnological offerings that involve the design, production, and optimization of AAV vectors tailored to specific research or therapeutic needs. These services are typically provided by biotech companies or research institutions and are widely used in gene therapy, genetic research, and preclinical studies. 
Custom AAV services are crucial for advancing gene therapy research and developing novel therapeutic approaches for genetic disorders. They provide researchers and clinicians with the tools needed to precisely manipulate gene expression in various cell types and tissues, facilitating the development of effective and targeted treatments.

North American market for Custom Adeno-Associated Virus (AAV) Services was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Custom Adeno-Associated Virus (AAV) Services was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Custom Adeno-Associated Virus (AAV) Services was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Custom Adeno-Associated Virus (AAV) Services include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed）, Gene Universal, Polyplus (Sartorius), etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Custom Adeno-Associated Virus (AAV) Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Custom Adeno-Associated Virus (AAV) Services by region & country, by Type, and by Application.

The Custom Adeno-Associated Virus (AAV) Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Adeno-Associated Virus (AAV) Services.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Custom Adeno-Associated Virus (AAV) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  • Market Size Available for Years

  • 2025-2031

  • Global Custom Adeno-Associated Virus (AAV) Services Companies Covered

  • Thermo Fisher Scientific

    Lonza

    Catalent

    Charles River

    Merck

    SK pharmteco

    Oxford Biomedica

    AGC Biologics（MolMed）

    Gene Universal

    Polyplus (Sartorius)

    CCRM

    FUJIFILM Diosynth Biotechnologies

    Biovian

    Miltenyi Bioindustry

    Aldevron

    Takara Bio

    Yposkesi

    Genezen

    Exthera

    GenScript ProBio

    EurekaBio

    Obio Technology

    GeneSail Biotech

    VectorBuilder

    WuXi ATU

    Ubrigene

    Porton Biologics

    Pharmaron

    PackGene Biotechnology

  • Global Custom Adeno-Associated Virus (AAV) Services Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Custom Adeno-Associated Virus (AAV) Services Market, Segment by Type

  • Adherent Culture

    Suspension Culture

  • Global Custom Adeno-Associated Virus (AAV) Services Market, Segment by Application

  • Vaccine Development

    Gene Therapy

    Academic Scientific Research Institution

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Custom Adeno-Associated Virus (AAV) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Custom Adeno-Associated Virus (AAV) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Custom Adeno-Associated Virus (AAV) Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Custom Adeno-Associated Virus (AAV) Services Product Introduction
    1.2 Global Custom Adeno-Associated Virus (AAV) Services Market Size Forecast (2020-2031)
    1.3 Custom Adeno-Associated Virus (AAV) Services Market Trends & Drivers
        1.3.1 Custom Adeno-Associated Virus (AAV) Services Industry Trends
        1.3.2 Custom Adeno-Associated Virus (AAV) Services Market Drivers & Opportunity
        1.3.3 Custom Adeno-Associated Virus (AAV) Services Market Challenges
        1.3.4 Custom Adeno-Associated Virus (AAV) Services Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Custom Adeno-Associated Virus (AAV) Services Players Revenue Ranking (2024)
    2.2 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Company (2020-2025)
    2.3 Key Companies Custom Adeno-Associated Virus (AAV) Services Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Custom Adeno-Associated Virus (AAV) Services Product Offered
    2.5 Key Companies Time to Begin Mass Production of Custom Adeno-Associated Virus (AAV) Services
    2.6 Custom Adeno-Associated Virus (AAV) Services Market Competitive Analysis
        2.6.1 Custom Adeno-Associated Virus (AAV) Services Market Concentration Rate (2020-2025)
        2.6.2 Global 5 and 10 Largest Companies by Custom Adeno-Associated Virus (AAV) Services Revenue in 2024
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Adeno-Associated Virus (AAV) Services as of 2024)
    2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Adherent Culture
        3.1.2 Suspension Culture
    3.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type
        3.2.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value, by Type (2020-2031)
        3.2.3 Global Custom Adeno-Associated Virus (AAV) Services Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Vaccine Development
        4.1.2 Gene Therapy
        4.1.3 Academic Scientific Research Institution
        4.1.4 Others
    4.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application
        4.2.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value, by Application (2020-2031)
        4.2.3 Global Custom Adeno-Associated Virus (AAV) Services Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
    5.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region
        5.1.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2020-2025)
        5.1.3 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2026-2031)
        5.1.4 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (%), (2020-2031)
    5.2 North America
        5.2.1 North America Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        5.2.2 North America Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
    5.3 Europe
        5.3.1 Europe Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        5.3.2 Europe Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
    5.4 Asia Pacific
        5.4.1 Asia Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        5.4.2 Asia Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (%), 2024 VS 2031
    5.5 South America
        5.5.1 South America Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        5.5.2 South America Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        5.6.2 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
    6.3 United States
        6.3.1 United States Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        6.3.2 United States Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Custom Adeno-Associated Virus (AAV) Services Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        6.4.2 Europe Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Custom Adeno-Associated Virus (AAV) Services Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        6.5.2 China Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Custom Adeno-Associated Virus (AAV) Services Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        6.6.2 Japan Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Custom Adeno-Associated Virus (AAV) Services Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        6.7.2 South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        6.8.2 Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020-2031
        6.9.2 India Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Custom Adeno-Associated Virus (AAV) Services Sales Value by Application, 2024 VS 2031
7 Company Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Profile
        7.1.2 Thermo Fisher Scientific Main Business
        7.1.3 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.1.4 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.1.5 Thermo Fisher Scientific Recent Developments
    7.2 Lonza
        7.2.1 Lonza Profile
        7.2.2 Lonza Main Business
        7.2.3 Lonza Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.2.4 Lonza Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.2.5 Lonza Recent Developments
    7.3 Catalent
        7.3.1 Catalent Profile
        7.3.2 Catalent Main Business
        7.3.3 Catalent Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.3.4 Catalent Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.3.5 Catalent Recent Developments
    7.4 Charles River
        7.4.1 Charles River Profile
        7.4.2 Charles River Main Business
        7.4.3 Charles River Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.4.4 Charles River Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.4.5 Charles River Recent Developments
    7.5 Merck
        7.5.1 Merck Profile
        7.5.2 Merck Main Business
        7.5.3 Merck Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.5.4 Merck Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.5.5 Merck Recent Developments
    7.6 SK pharmteco
        7.6.1 SK pharmteco Profile
        7.6.2 SK pharmteco Main Business
        7.6.3 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.6.4 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.6.5 SK pharmteco Recent Developments
    7.7 Oxford Biomedica
        7.7.1 Oxford Biomedica Profile
        7.7.2 Oxford Biomedica Main Business
        7.7.3 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.7.4 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.7.5 Oxford Biomedica Recent Developments
    7.8 AGC Biologics（MolMed）
        7.8.1 AGC Biologics（MolMed） Profile
        7.8.2 AGC Biologics（MolMed） Main Business
        7.8.3 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.8.4 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.8.5 AGC Biologics（MolMed） Recent Developments
    7.9 Gene Universal
        7.9.1 Gene Universal Profile
        7.9.2 Gene Universal Main Business
        7.9.3 Gene Universal Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.9.4 Gene Universal Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.9.5 Gene Universal Recent Developments
    7.10 Polyplus (Sartorius)
        7.10.1 Polyplus (Sartorius) Profile
        7.10.2 Polyplus (Sartorius) Main Business
        7.10.3 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.10.4 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.10.5 Polyplus (Sartorius) Recent Developments
    7.11 CCRM
        7.11.1 CCRM Profile
        7.11.2 CCRM Main Business
        7.11.3 CCRM Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.11.4 CCRM Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.11.5 CCRM Recent Developments
    7.12 FUJIFILM Diosynth Biotechnologies
        7.12.1 FUJIFILM Diosynth Biotechnologies Profile
        7.12.2 FUJIFILM Diosynth Biotechnologies Main Business
        7.12.3 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.12.4 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments
    7.13 Biovian
        7.13.1 Biovian Profile
        7.13.2 Biovian Main Business
        7.13.3 Biovian Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.13.4 Biovian Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.13.5 Biovian Recent Developments
    7.14 Miltenyi Bioindustry
        7.14.1 Miltenyi Bioindustry Profile
        7.14.2 Miltenyi Bioindustry Main Business
        7.14.3 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.14.4 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.14.5 Miltenyi Bioindustry Recent Developments
    7.15 Aldevron
        7.15.1 Aldevron Profile
        7.15.2 Aldevron Main Business
        7.15.3 Aldevron Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.15.4 Aldevron Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.15.5 Aldevron Recent Developments
    7.16 Takara Bio
        7.16.1 Takara Bio Profile
        7.16.2 Takara Bio Main Business
        7.16.3 Takara Bio Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.16.4 Takara Bio Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.16.5 Takara Bio Recent Developments
    7.17 Yposkesi
        7.17.1 Yposkesi Profile
        7.17.2 Yposkesi Main Business
        7.17.3 Yposkesi Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.17.4 Yposkesi Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.17.5 Yposkesi Recent Developments
    7.18 Genezen
        7.18.1 Genezen Profile
        7.18.2 Genezen Main Business
        7.18.3 Genezen Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.18.4 Genezen Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.18.5 Genezen Recent Developments
    7.19 Exthera
        7.19.1 Exthera Profile
        7.19.2 Exthera Main Business
        7.19.3 Exthera Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.19.4 Exthera Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.19.5 Exthera Recent Developments
    7.20 GenScript ProBio
        7.20.1 GenScript ProBio Profile
        7.20.2 GenScript ProBio Main Business
        7.20.3 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.20.4 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.20.5 GenScript ProBio Recent Developments
    7.21 EurekaBio
        7.21.1 EurekaBio Profile
        7.21.2 EurekaBio Main Business
        7.21.3 EurekaBio Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.21.4 EurekaBio Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.21.5 EurekaBio Recent Developments
    7.22 Obio Technology
        7.22.1 Obio Technology Profile
        7.22.2 Obio Technology Main Business
        7.22.3 Obio Technology Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.22.4 Obio Technology Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.22.5 Obio Technology Recent Developments
    7.23 GeneSail Biotech
        7.23.1 GeneSail Biotech Profile
        7.23.2 GeneSail Biotech Main Business
        7.23.3 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.23.4 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.23.5 GeneSail Biotech Recent Developments
    7.24 VectorBuilder
        7.24.1 VectorBuilder Profile
        7.24.2 VectorBuilder Main Business
        7.24.3 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.24.4 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.24.5 VectorBuilder Recent Developments
    7.25 WuXi ATU
        7.25.1 WuXi ATU Profile
        7.25.2 WuXi ATU Main Business
        7.25.3 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.25.4 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.25.5 WuXi ATU Recent Developments
    7.26 Ubrigene
        7.26.1 Ubrigene Profile
        7.26.2 Ubrigene Main Business
        7.26.3 Ubrigene Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.26.4 Ubrigene Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.26.5 Ubrigene Recent Developments
    7.27 Porton Biologics
        7.27.1 Porton Biologics Profile
        7.27.2 Porton Biologics Main Business
        7.27.3 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.27.4 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.27.5 Porton Biologics Recent Developments
    7.28 Pharmaron
        7.28.1 Pharmaron Profile
        7.28.2 Pharmaron Main Business
        7.28.3 Pharmaron Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.28.4 Pharmaron Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.28.5 Pharmaron Recent Developments
    7.29 PackGene Biotechnology
        7.29.1 PackGene Biotechnology Profile
        7.29.2 PackGene Biotechnology Main Business
        7.29.3 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
        7.29.4 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) & (2020-2025)
        7.29.5 PackGene Biotechnology Recent Developments
8 Industry Chain Analysis
    8.1 Custom Adeno-Associated Virus (AAV) Services Industrial Chain
    8.2 Custom Adeno-Associated Virus (AAV) Services Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Custom Adeno-Associated Virus (AAV) Services Sales Model
        8.5.2 Sales Channel
        8.5.3 Custom Adeno-Associated Virus (AAV) Services Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Custom Adeno-Associated Virus (AAV) Services Market Trends
 Table 2. Custom Adeno-Associated Virus (AAV) Services Market Drivers & Opportunity
 Table 3. Custom Adeno-Associated Virus (AAV) Services Market Challenges
 Table 4. Custom Adeno-Associated Virus (AAV) Services Market Restraints
 Table 5. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Custom Adeno-Associated Virus (AAV) Services Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Custom Adeno-Associated Virus (AAV) Services Product Type
 Table 9. Key Companies Time to Begin Mass Production of Custom Adeno-Associated Virus (AAV) Services
 Table 10. Global Custom Adeno-Associated Virus (AAV) Services Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Adeno-Associated Virus (AAV) Services as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Custom Adeno-Associated Virus (AAV) Services Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Custom Adeno-Associated Virus (AAV) Services Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Custom Adeno-Associated Virus (AAV) Services Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Custom Adeno-Associated Virus (AAV) Services Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2020-2025) & (%)
 Table 27. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Custom Adeno-Associated Virus (AAV) Services Sales Value, (2026-2031) & (US$ Million)
 Table 31. Thermo Fisher Scientific Basic Information List
 Table 32. Thermo Fisher Scientific Description and Business Overview
 Table 33. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Thermo Fisher Scientific (2020-2025)
 Table 35. Thermo Fisher Scientific Recent Developments
 Table 36. Lonza Basic Information List
 Table 37. Lonza Description and Business Overview
 Table 38. Lonza Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Lonza (2020-2025)
 Table 40. Lonza Recent Developments
 Table 41. Catalent Basic Information List
 Table 42. Catalent Description and Business Overview
 Table 43. Catalent Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Catalent (2020-2025)
 Table 45. Catalent Recent Developments
 Table 46. Charles River Basic Information List
 Table 47. Charles River Description and Business Overview
 Table 48. Charles River Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Charles River (2020-2025)
 Table 50. Charles River Recent Developments
 Table 51. Merck Basic Information List
 Table 52. Merck Description and Business Overview
 Table 53. Merck Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Merck (2020-2025)
 Table 55. Merck Recent Developments
 Table 56. SK pharmteco Basic Information List
 Table 57. SK pharmteco Description and Business Overview
 Table 58. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of SK pharmteco (2020-2025)
 Table 60. SK pharmteco Recent Developments
 Table 61. Oxford Biomedica Basic Information List
 Table 62. Oxford Biomedica Description and Business Overview
 Table 63. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Oxford Biomedica (2020-2025)
 Table 65. Oxford Biomedica Recent Developments
 Table 66. AGC Biologics（MolMed） Basic Information List
 Table 67. AGC Biologics（MolMed） Description and Business Overview
 Table 68. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of AGC Biologics（MolMed） (2020-2025)
 Table 70. AGC Biologics（MolMed） Recent Developments
 Table 71. Gene Universal Basic Information List
 Table 72. Gene Universal Description and Business Overview
 Table 73. Gene Universal Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Gene Universal (2020-2025)
 Table 75. Gene Universal Recent Developments
 Table 76. Polyplus (Sartorius) Basic Information List
 Table 77. Polyplus (Sartorius) Description and Business Overview
 Table 78. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Polyplus (Sartorius) (2020-2025)
 Table 80. Polyplus (Sartorius) Recent Developments
 Table 81. CCRM Basic Information List
 Table 82. CCRM Description and Business Overview
 Table 83. CCRM Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of CCRM (2020-2025)
 Table 85. CCRM Recent Developments
 Table 86. FUJIFILM Diosynth Biotechnologies Basic Information List
 Table 87. FUJIFILM Diosynth Biotechnologies Description and Business Overview
 Table 88. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of FUJIFILM Diosynth Biotechnologies (2020-2025)
 Table 90. FUJIFILM Diosynth Biotechnologies Recent Developments
 Table 91. Biovian Basic Information List
 Table 92. Biovian Description and Business Overview
 Table 93. Biovian Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Biovian (2020-2025)
 Table 95. Biovian Recent Developments
 Table 96. Miltenyi Bioindustry Basic Information List
 Table 97. Miltenyi Bioindustry Description and Business Overview
 Table 98. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Miltenyi Bioindustry (2020-2025)
 Table 100. Miltenyi Bioindustry Recent Developments
 Table 101. Aldevron Basic Information List
 Table 102. Aldevron Description and Business Overview
 Table 103. Aldevron Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Aldevron (2020-2025)
 Table 105. Aldevron Recent Developments
 Table 106. Takara Bio Basic Information List
 Table 107. Takara Bio Description and Business Overview
 Table 108. Takara Bio Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 109. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Takara Bio (2020-2025)
 Table 110. Takara Bio Recent Developments
 Table 111. Yposkesi Basic Information List
 Table 112. Yposkesi Description and Business Overview
 Table 113. Yposkesi Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 114. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Yposkesi (2020-2025)
 Table 115. Yposkesi Recent Developments
 Table 116. Genezen Basic Information List
 Table 117. Genezen Description and Business Overview
 Table 118. Genezen Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 119. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Genezen (2020-2025)
 Table 120. Genezen Recent Developments
 Table 121. Exthera Basic Information List
 Table 122. Exthera Description and Business Overview
 Table 123. Exthera Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 124. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Exthera (2020-2025)
 Table 125. Exthera Recent Developments
 Table 126. GenScript ProBio Basic Information List
 Table 127. GenScript ProBio Description and Business Overview
 Table 128. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 129. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of GenScript ProBio (2020-2025)
 Table 130. GenScript ProBio Recent Developments
 Table 131. EurekaBio Basic Information List
 Table 132. EurekaBio Description and Business Overview
 Table 133. EurekaBio Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 134. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of EurekaBio (2020-2025)
 Table 135. EurekaBio Recent Developments
 Table 136. Obio Technology Basic Information List
 Table 137. Obio Technology Description and Business Overview
 Table 138. Obio Technology Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 139. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Obio Technology (2020-2025)
 Table 140. Obio Technology Recent Developments
 Table 141. GeneSail Biotech Basic Information List
 Table 142. GeneSail Biotech Description and Business Overview
 Table 143. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 144. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of GeneSail Biotech (2020-2025)
 Table 145. GeneSail Biotech Recent Developments
 Table 146. VectorBuilder Basic Information List
 Table 147. VectorBuilder Description and Business Overview
 Table 148. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 149. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of VectorBuilder (2020-2025)
 Table 150. VectorBuilder Recent Developments
 Table 151. WuXi ATU Basic Information List
 Table 152. WuXi ATU Description and Business Overview
 Table 153. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 154. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of WuXi ATU (2020-2025)
 Table 155. WuXi ATU Recent Developments
 Table 156. Ubrigene Basic Information List
 Table 157. Ubrigene Description and Business Overview
 Table 158. Ubrigene Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 159. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Ubrigene (2020-2025)
 Table 160. Ubrigene Recent Developments
 Table 161. Porton Biologics Basic Information List
 Table 162. Porton Biologics Description and Business Overview
 Table 163. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 164. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Porton Biologics (2020-2025)
 Table 165. Porton Biologics Recent Developments
 Table 166. Pharmaron Basic Information List
 Table 167. Pharmaron Description and Business Overview
 Table 168. Pharmaron Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 169. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of Pharmaron (2020-2025)
 Table 170. Pharmaron Recent Developments
 Table 171. PackGene Biotechnology Basic Information List
 Table 172. PackGene Biotechnology Description and Business Overview
 Table 173. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Products, Services and Solutions
 Table 174. Revenue (US$ Million) in Custom Adeno-Associated Virus (AAV) Services Business of PackGene Biotechnology (2020-2025)
 Table 175. PackGene Biotechnology Recent Developments
 Table 176. Key Raw Materials Lists
 Table 177. Raw Materials Key Suppliers Lists
 Table 178. Custom Adeno-Associated Virus (AAV) Services Downstream Customers
 Table 179. Custom Adeno-Associated Virus (AAV) Services Distributors List
 Table 180. Research Programs/Design for This Report
 Table 181. Key Data Information from Secondary Sources
 Table 182. Key Data Information from Primary Sources


List of Figures
 Figure 1. Custom Adeno-Associated Virus (AAV) Services Product Picture
 Figure 2. Global Custom Adeno-Associated Virus (AAV) Services Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Custom Adeno-Associated Virus (AAV) Services Sales Value (2020-2031) & (US$ Million)
 Figure 4. Custom Adeno-Associated Virus (AAV) Services Report Years Considered
 Figure 5. Global Custom Adeno-Associated Virus (AAV) Services Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Custom Adeno-Associated Virus (AAV) Services Revenue in 2024
 Figure 7. Custom Adeno-Associated Virus (AAV) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Adherent Culture Picture
 Figure 9. Suspension Culture Picture
 Figure 10. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 11. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Market Share by Type, 2024 & 2031
 Figure 12. Product Picture of Vaccine Development
 Figure 13. Product Picture of Gene Therapy
 Figure 14. Product Picture of Academic Scientific Research Institution
 Figure 15. Product Picture of Others
 Figure 16. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Market Share by Application, 2024 & 2031
 Figure 18. North America Custom Adeno-Associated Virus (AAV) Services Sales Value (2020-2031) & (US$ Million)
 Figure 19. North America Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
 Figure 20. Europe Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 21. Europe Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
 Figure 22. Asia Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 23. Asia Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (%), 2024 VS 2031
 Figure 24. South America Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 25. South America Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
 Figure 26. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 27. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (%), 2024 VS 2031
 Figure 28. Key Countries/Regions Custom Adeno-Associated Virus (AAV) Services Sales Value (%), (2020-2031)
 Figure 29. United States Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 30. United States Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
 Figure 31. United States Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (%), 2024 VS 2031
 Figure 32. Europe Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Europe Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
 Figure 34. Europe Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (%), 2024 VS 2031
 Figure 35. China Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 36. China Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
 Figure 37. China Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (%), 2024 VS 2031
 Figure 38. Japan Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 39. Japan Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
 Figure 40. Japan Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (%), 2024 VS 2031
 Figure 41. South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 42. South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
 Figure 43. South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (%), 2024 VS 2031
 Figure 44. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
 Figure 46. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (%), 2024 VS 2031
 Figure 47. India Custom Adeno-Associated Virus (AAV) Services Sales Value, (2020-2031) & (US$ Million)
 Figure 48. India Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (%), 2024 VS 2031
 Figure 49. India Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (%), 2024 VS 2031
 Figure 50. Custom Adeno-Associated Virus (AAV) Services Industrial Chain
 Figure 51. Custom Adeno-Associated Virus (AAV) Services Manufacturing Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed

Description

The global market for Custom Adeno-Associated Virus (AAV) Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Custom Adeno-Associated Virus (AAV) services refer to specialized biotechnological offerings that involve the design, production, and optimization of AAV vectors tailored to specific research or therapeutic needs. These services are typically provided by biotech companies or research institutions and are widely used in gene therapy, genetic research, and preclinical studies. 
Custom AAV services are crucial for advancing gene therapy research and developing novel therapeutic approaches for genetic disorders. They provide researchers and clinicians with the tools needed to precisely manipulate gene expression in various cell types and tissues, facilitating the development of effective and targeted treatments.

North American market for Custom Adeno-Associated Virus (AAV) Services was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Custom Adeno-Associated Virus (AAV) Services was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Custom Adeno-Associated Virus (AAV) Services was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Custom Adeno-Associated Virus (AAV) Services include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed）, Gene Universal, Polyplus (Sartorius), etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Custom Adeno-Associated Virus (AAV) Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Custom Adeno-Associated Virus (AAV) Services by region & country, by Type, and by Application.

The Custom Adeno-Associated Virus (AAV) Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Adeno-Associated Virus (AAV) Services.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Custom Adeno-Associated Virus (AAV) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Custom Adeno-Associated Virus (AAV) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Custom Adeno-Associated Virus (AAV) Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Custom Adeno-Associated Virus (AAV) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published: 2025-03-11

Pages: 169 Pages

Report ld: 4641384

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now